On Janaushadhi Diwas this year (i.e., March 7th, 2022), Prime Minister Shri Narendra Modi stated that the poor and the middle-class benefited from the 'Jan Aushadhi Kendras' that were set up to provide generic drugs at affordable prices. He said that the poor and the middle class saved around Rs.13,000 crore through these stores during the COVID-19 pandemic. In the wake of COVID 19 crisis, the 'Bureau of Pharma PSUs of India'...
More »SEARCH RESULT
Total Matching Records found : 419
Reality is stranger than the fad for online education -- most schools lack IT-infrastructure
Online teaching was perhaps the most preferred mode (of the policymakers) for imparting education to school children in the last two years when schools faced closures thanks to the COVID-19 pandemic. It was promoted by both the Central and State Governments when mobility almost came to a standstill (or got restricted in comparison to normal times) during the last two years. However, various studies (a list of those studies is...
More »India’s facade of agricultural insurance -Shagun, Priya Ranjan Sahu, Rakesh Kumar Malviya, Shuchita Jha and M Raghuram
-Down to Earth Since its launch in 2016, India’s flagship crop insurance scheme has seen a consistent fall in acreage and number of farmers covered Even if a single farmer’s crop is damaged in a village he will get the benefits of insurance - Prime Minister Narendra Modi had said while launching the government’s flagship Pradhan Mantri Fasal Bima Yojana (PMFBY) from Madhya Pradesh in 2016. The words, however, mean nothing to the farmers...
More »Voluntary Licensing Agreements between MPP and Big Pharma – Increasing Monopoly Power -Richa Chintan
-Newsclick.in The recent agreements between Medicine Patent Pool and Big Pharma are being projected as benevolent gestures from pharma companies in sharing their patented technologies with other countries. The fact is it is working towards cementing its monopoly power further. The development of anti-viral oral pills to combat COVID-19 will, hopefully, make the fight against the pandemic more promising. While Merck has developed the anti-viral pill Molnupiravir, Pfizer has come up with...
More »Water is not a commodity and financial asset to be exploited, says UN human rights expert
--Press release by Office of the United Nations High Commissioner for Human Rights dated 20th October, 2021 GENEVA (20 October 2021) – Water is increasingly being treated as a mere commodity and even as a financial asset, a UN human rights expert told the UN General Assembly today, undermining the human rights to safe drinking water and sanitation and the sustainability of the environment. Pedro Arrojo Agudo, the Special Rapporteur on the...
More »
